Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (161-170 of 663) with videos related to

Pageof 67
Sort By:
Cell Reports|April 28, 2021
Characterization of HIV-induced remodeling reveals differences in infection susceptibility of memory CD4<sup>+</sup> T cell subsets in vivoGuorui Xie, Xiaoyu Luo, Tongcui Ma, et al.
AIDS (London, England)|January 31, 2003
Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment responseSteven G Deeks, Robert M Grant, Terri Wrin, et al.
The Journal of Infectious Diseases|October 6, 2005
Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infectionSteven G Deeks, Rebecca Hoh, Torsten B Neilands, et al.
AIDS (London, England)|June 13, 2014
A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veteransRebecca Scherzer, Monica Gandhi, Michelle M Estrella, et al.
Plos One|October 11, 2012
Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencingGuinevere Q Lee, Luke C Swenson, Art F Y Poon, et al.
AIDS (London, England)|March 20, 2010
Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammationJohn C Probasco, Steven G Deeks, Evelyn Lee, et al.
AIDS (London, England)|March 3, 2006
Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitnessDavid R Bangsberg, Edward P Acosta, Reena Gupta, et al.
Journal of Virology|August 2, 2013
AIDS alters the commensal plasma viromeLinlin Li, Xutao Deng, Piyada Linsuwanon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2018
Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral TherapyAdam W Carrico, Peter W Hunt, Torsten B Neilands, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence levelViviane D Lima, David R Bangsberg, P Richard Harrigan, et al.
Pageof 67

Showing results (161-170 of 663) with videos related to

Sort By:
Pageof 67
Cell Reports|April 28, 2021
Characterization of HIV-induced remodeling reveals differences in infection susceptibility of memory CD4<sup>+</sup> T cell subsets in vivoGuorui Xie, Xiaoyu Luo, Tongcui Ma, et al.
AIDS (London, England)|January 31, 2003
Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment responseSteven G Deeks, Robert M Grant, Terri Wrin, et al.
The Journal of Infectious Diseases|October 6, 2005
Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infectionSteven G Deeks, Rebecca Hoh, Torsten B Neilands, et al.
AIDS (London, England)|June 13, 2014
A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veteransRebecca Scherzer, Monica Gandhi, Michelle M Estrella, et al.
Plos One|October 11, 2012
Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencingGuinevere Q Lee, Luke C Swenson, Art F Y Poon, et al.
AIDS (London, England)|March 20, 2010
Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammationJohn C Probasco, Steven G Deeks, Evelyn Lee, et al.
AIDS (London, England)|March 3, 2006
Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitnessDavid R Bangsberg, Edward P Acosta, Reena Gupta, et al.
Journal of Virology|August 2, 2013
AIDS alters the commensal plasma viromeLinlin Li, Xutao Deng, Piyada Linsuwanon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2018
Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral TherapyAdam W Carrico, Peter W Hunt, Torsten B Neilands, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence levelViviane D Lima, David R Bangsberg, P Richard Harrigan, et al.
Pageof 67